All of these findings confirmed that Sec C had distinct inhibitory effects on colorectal tumor cells and induced obvious tumor cell death, suggesting that Sec C could be developed as a prodrug for further clinical treatment for cancers. The gene discussed is SIAE; the disease is neoplasm.